LISA KERN: Open Payments
NPI 1104989961 · GALLOWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 22 payments from 13 companies in 2025. Trend: 2023 $1,154 · 2024 $455 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $153 |
| AstraZeneca Pharmaceuticals LP | 3 | $116 |
| ABIOMED | 3 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $50 |
| Baxter Healthcare | 1 | $42 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Novo Nordisk Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| GENZYME CORPORATION | 1 | $18 |
Products named: Attruby, LifeVest, PERCLOT, FUROSCIX, Wegovy, NUCALA, DUPIXENT, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
